DISHMAN

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Update on Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd., Carbogen Amcis (India) Limited and Dishman Care Limited and their respective Shareholders & Creditors.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Update on Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd., Carbogen Amcis (India) Limited and Dishman Care Limited and their respective Shareholders & Creditors

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Order from Hon'ble High Court of Gujarat sanctioning Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd., Carbogen Amcis (India) Limited and Dishman Care Limited and their respective Shareholders & Creditors

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that: "Dishman Acquired Fine Chemicals and Vitamin D Business From Solvay. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)."<a href=/content/corporate/Dishman_acq_31102007.zip target=NEW> For more details click here.</a>

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the company ("Dishman") on August 23,2006 announced that it has acquired CARBOGEN AMCIS AG ("CA"), a Swiss Research based company with the three production facilities in Switzerland for manufacture of high potent high value products from Solutia Europe SA/NV ("SESA"). Dishman paid to SESA over US$ 75 million (inclusive of around Us $ 9 million for working capital) and took over the shares and assets of CARBOGEN AMCIS, through its wholly owned subsidiary namely Dishman Pharma Solutions AG ("DPS") in Burssels on August

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the company has acquired a Bern,Switzerland based contract research company,M/s IO3S Ltd.(IO3S),through its 100% wholly owned Switzerland based subsidiary company M/s.Dishman Switzerland Limited.Further, details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the Company has acquired a Manchester U.K. based Contract Research Company, M/s Synprotec Ltd., through its 100% wholly owned U.K. based subsidiary company M/s Dishman Europe Ltd.. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).